Patent details

Basic Information

Publication number:

EP3154559

PCT Application Number:

IB2015054399

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157308586

PCT Publication Number:

WO2015189790

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF SERELAXIN TO REDUCE GDF-15

French Title of Invention:

UTILISATION DE SÉRÉLAXINE POUR RÉDUIRE LE GDF-15

German Title of Invention:

VERWENDUNG VON SERELAXIN ZUR REDUZIERUNG VON GDF-15

SPC Number:

Dates

Filing date:

10/06/2015

Grant date:

01/09/2021

EP Publication Date:

19/04/2017

PCT Publication Date:

17/12/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/09/2021

EP B1 Publication Date:

01/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/06/2022

Expiration date:

10/06/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/08/2021

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

PRESCOTT, Margaret Forney

Address:

United States (US)

2

Name:

ZHANG, Yiming

Address:

United States (US)

3

Name:

SEVERIN, Thomas

Address:

Switzerland (CH)

4

Name:

DAHLKE, Marion

Address:

Switzerland (CH)

Priority

Priority Number:

201462011744 P

Priority Date:

13/06/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 38/22; A61B 5/00; A61P 9/00; A61P 11/00; A61P 9/04;

Publication

European Patent Bulletin

Issue number:

202135

Publication date:

01/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages